SavedAdd your journal

Journals / Turkish Neurosurgery / 2013 / Cilt: 23 - Sayı: 5

Derin Beyin Stimülasyonu Uygulanan Parkinson Hastalarında T2W MR da Probe Eye ile Ölçülen Subtalamik Nukleus Uzunluğu, Mikroelektrod Kayıtla Uyumlu mu?

Does Probe's Eye Subthalamic nucleus length on T2W MRI Correspond with Microelectrode Recording in Patients with Deep Brain Stimulation for Advanced Parkinson's Disease?

Ersoy KOCABICAK
Omer BOKE
Murat KURT
Hatice GUZ
Dursun AYGUN
Murat TERZI
Musa ONAR
Ilkay OZAYDIN
Ali JAHANSHAHI
K. H TAN SONNY
Onur ALPTEKIN
Yasin TEMEL
Pages
658–665
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The length of the STNin the probe s eye view mode was calculated along the trajectory of the central MER electrode crossing the STN.Results: Our analysis showed no statistical difference between the length of the STN measured with the T2 weighted probe s eye view modeand the MER (right STN length 5.8 ± 0.9 mm MRI vs. 6.3 ± 0.5 mm MER, p>0.05; left STN length 5.6 ± 0.4 mm MRI vs 5.8 ± 1 mm MER, p>0.05).CONCLUSION: This means that the entry and the exit of the STN can be adequately estimated using the probe s eye view preoperatively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AIM: Subthalamic nucleus (STN) deep brain stimulation (DBS) has become a well-accepted treatment for patients with advanced Parkinson sdisease (PD).
📊
Key Findings & Data:Here, we addressed the question to which extent the length of the STN measured with the T2 weighted MRI in the probe s eyeview corresponded with the intraoperatively determined length of the STN with MER.MATERIAL and METHODS: We included 10 consecutive Parkinson s disease patients who underwent STN DBS surgery.
💡
Conclusion & Impact:The length of the STNin the probe s eye view mode was calculated along the trajectory of the central MER electrode crossing the STN.Results: Our analysis showed no statistical difference between the length of the STN measured with the T2 weighted probe s eye view modeand the MER (right STN length 5.8 ± 0.9 mm MRI vs. 6.3 ± 0.5 mm MER, p>0.05; left STN length 5.6 ± 0.4 mm MRI vs 5.8 ± 1 mm MER, p>0.05).CONCLUSION: This means that the entry and the exit of the STN can be adequately estimated using the probe s eye view preoperatively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AIM: Subthalamic nucleus (STN) deep brain stimulation (DBS) has become a well-accepted treatment for patients with advanced Parkinson sdisease (PD). During surgical planning for DBS, the length of the STN is taken into account and verified during microelectrode recording (MER)intraoperatively. Here, we addressed the question to which extent the length of the STN measured with the T2 weighted MRI in the probe s eyeview corresponded with the intraoperatively determined length of the STN with MER.MATERIAL and METHODS: We included 10 consecutive Parkinson s disease patients who underwent STN DBS surgery. The length of the STNin the probe s eye view mode was calculated along the trajectory of the central MER electrode crossing the STN.Results: Our analysis showed no statistical difference between the length of the STN measured with the T2 weighted probe s eye view modeand the MER (right STN length 5.8 ± 0.9 mm MRI vs. 6.3 ± 0.5 mm MER, p>0.05; left STN length 5.6 ± 0.4 mm MRI vs 5.8 ± 1 mm MER, p>0.05).CONCLUSION: This means that the entry and the exit of the STN can be adequately estimated using the probe s eye view preoperatively.

Özet

AMAÇ: STN DBS ilerlemiş Parkinson hastalığı olan hastaların tedavisinde kabul görmüş bir tedavi metodudur. Derin beyin stimülasyonunun(DBS) cerrahi planlaması yapılırken subtalamik nukleusun (STN) uzunluğu göz önünde bulundurulur ve intraoperatif olarak mikroelektrodkayıtla (MER) doğrulanır. Bu çalışmada T2 ağırlıklı MRda probe eye ile ölçülen STN uzunluğunun intraoperatif MERle ölçülen STN uzunluğu ilene kadar örtüştüğünü araştırdık.yÖntem ve GeReÇleR: STN DBS cerrahisi uygulanan 10 Parkinson hastasını inceledik. Probe eye görüntüdeki STN uzunluğu ve STNi geçensantral MER elektrodunun trasesinin uzunluğu hesaplandı. BULGULAR: Analizimiz T2 ağırlıklı probe eye görüntüdeki STN uzunluğu ile MER arasında istatistiksel açıdan anlamlı fark olmadığını gösterdi. SONUÇ: STNnin giriş ve çıkış noktaları preoperatif probe eye görüntüsü kullanılarak doğru bir şekilde belirlenebilir.

🔖

Cite This Article

KOCABICAK, E., BOKE, O., KURT, M., GUZ, H., AYGUN, D., TERZI, M., ONAR, M., OZAYDIN, I., JAHANSHAHI, A., SONNY, K. H. T., ALPTEKIN, O., TEMEL, Y. (2022). Derin Beyin Stimülasyonu Uygulanan Parkinson Hastalarında T2W MR da Probe Eye ile Ölçülen Subtalamik Nukleus Uzunluğu, Mikroelektrod Kayıtla Uyumlu mu?. Turkish Neurosurgery, Cilt: 23 - Sayı: 5, 658–665. https://ajindex.com/articles/616999

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Acar F, Miller JP, Berk MC, Anderson G, Burchiel KJ: Safety o anterior commissure-posterior commissure-based target cal culation of the subthalamic nucleus in functional stereotacti procedures. Stereotact Funct Neurosurg. 85(6):287-291, 2007 2. Binder DK, Rau GM, Starr PA: Risk factors for hemorrhage during microelectrode- guided deep brain stimulator imp lantation for movement disorders. Neurosurgery 56(4) 722–732, 2005 3. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfe H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisne W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, Kloss M Koy J, Krause M, Kupsch A, Lorenz D, Lorenzl S, Mehdorn HM Moringlane JR, Oertel W, Pinsker MO, Reichmann H, Reuss A Schneider GH, Schnitzler A, Steude U, Sturm V, Timmerman L, Tronnier V, Trottenberg T, Wojtecki L, Wolf E, Poewe W, Voge J
  2. German Parkinson Study Group, Neurostimulation Section A randomized trial of deep-brain stimulation for Parkinson’ disease. N Engl J Med 355:896-908, 2006 4. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchie K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ
  3. CSP 468 Study Group: Pallida versus subthalamic deep-brain stimulation for Parkinson’ disease. N Engl J Med 362(22):2077-2091, 2010 5. Hamani C, Richter EO, Andrade-Souza Y, Hutchison W, Saint Cyr JA, Lozano AM: Correspondence of microelectrode mapping with magnetic resonance imaging for subthalami nucleus procedures. Surg Neurol 63(3):249-253, 2005 6. Hariz MI: Safety and risk of microelectrode recording i surgery for movement disorders. Stereotact Funct Neurosurg 78: 146–157, 2002 7. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349:1925-1934, 2003 8. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Le Bas JF, Broussolle E, Perret JE, Benabid AL: Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345: 91-95, 1995 9. Mandat TS, Hurwitz T, Honey CR: Hypomania as an adverse effect of subthalamic nucleus stimulation: Report of two cases. Acta Neurochir 148(8):895-897
  4. discussion 898, 2006 10. Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, Beute G